|
TFDP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.708800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.611800E-01 |
| Normal-vs-Stage2 |
9.643600E-02 |
| Normal-vs-Stage3 |
6.627000E-01 |
| Normal-vs-Stage4 |
5.169800E-01 |
| Stage1-vs-Stage2 |
7.765700E-02 |
| Stage1-vs-Stage3 |
4.221000E-01 |
| Stage1-vs-Stage4 |
5.624400E-01 |
| Stage2-vs-Stage3 |
2.516300E-02 |
| Stage2-vs-Stage4 |
3.293600E-01 |
| Stage3-vs-Stage4 |
2.585000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.690000E-01 |
| Normal-vs-AfricanAmerican |
9.696400E-03 |
| Normal-vs-Asian |
5.652400E-01 |
| Caucasian-vs-AfricanAmerican |
3.256700E-03 |
| Caucasian-vs-Asian |
4.911600E-01 |
| AfricanAmerican-vs-Asian |
2.302100E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.560800E-01 |
| Normal-vs-Female |
9.841400E-01 |
| Male-vs-Female |
1.694830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.724800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.676200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.991810E-01 |
| Normal-vs-Age(81-100Yrs) |
2.188000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.998000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.356000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.365200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.138000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.207200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.173400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.448000E-01 |
| Classical-VS-Follicular |
4.06699999999649E-05 |
| Classical-VS-Other |
7.439200E-01 |
| Classical-VS-Normal |
5.304000E-01 |
| Tall-VS-Follicular |
2.446500E-04 |
| Tall-VS-Other |
4.624400E-01 |
| Tall-VS-Normal |
2.944400E-01 |
| Follicular-VS-Other |
2.848800E-01 |
| Follicular-VS-Normal |
6.556800E-03 |
| Other-VS-Normal |
9.448800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.108000E-01 |
| Normal-vs-N1 |
6.048400E-01 |
| N0-vs-N1 |
7.458000E-01 |
|
|
